Comparing Waters (NYSE:WAT) and ADB International Group (OTCMKTS:EQUR)

ADB International Group (OTCMKTS:EQUR) and Waters (NYSE:WAT) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk.

Profitability

This table compares ADB International Group and Waters’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ADB International Group	N/A	N/A	N/A
Waters	20.30%	34.79%	16.29%

Institutional and Insider Ownership

94.0% of Waters shares are owned by institutional investors. 79.6% of ADB International Group shares are owned by insiders. Comparatively, 0.6% of Waters shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of current recommendations for ADB International Group and Waters, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ADB International Group	0	0	0	0	0.00
Waters	0	9	10	2	2.67

Waters has a consensus price target of $393.84, suggesting a potential upside of 31.51%. Given Waters’ stronger consensus rating and higher possible upside, analysts plainly believe Waters is more favorable than ADB International Group.

Earnings and Valuation

This table compares ADB International Group and Waters”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ADB International Group	N/A	N/A	N/A	N/A	N/A
Waters	$3.17 billion	9.28	$642.63 million	$10.77	27.81

Waters has higher revenue and earnings than ADB International Group.

Summary

Waters beats ADB International Group on 9 of the 10 factors compared between the two stocks.

About ADB International Group

E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.